DUBLIN--(BUSINESS WIRE)--
ICON plc., (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider of
outsourced development services to the pharmaceutical, biotechnology and
medical device industries, today announced the retirement of
Non-Executive Director, Dr. Anthony Murphy to become effective on 31st
December 2011.
Commenting on the announcement, ICON plc. Chairman, Dr. Bruce Given
said: "I would like to express the Board's thanks and appreciation for
Tony's advice and support during his time on the Board and to convey the
Board's best wishes to him for the future".
About ICON plc.
ICON plc. is a global provider of outsourced development services to the
pharmaceutical, biotechnology and medical device industries. The Company
specialises in the strategic development, management and analysis of
programs that support clinical development - from compound selection to
Phase I-IV clinical studies. ICON currently has approximately 8,300
employees, operating from 77 locations in 39 countries.
Further information is available at www.iconplc.com
Cautionary Note Regarding Forward-Looking Statements:
This release contains, and our officers and representatives may from
time to time make, "forward-looking statements" within the meaning of
the safe harbor provisions of the U.S. Private Securities Litigation
Reform Act of 1995. Forward-looking statements can be identified by
words such as: "anticipate," "intend," "plan," "expect," "strategy" and
similar references to future periods. You should not rely on any of
these forward-looking statements.
ICON/ICLR-F
ICON plc
Investor Relations
1-888-381-7923
or
Sam
Farthing VP Investor Relations
+ 353 —1-291-2000
Source: ICON plc.
News Provided by Acquire Media
